Affiliated with GIBH-Chinese Academy of Sciences
9th September 2010
Therapies
Awards
Stories
0】
【
MERASA LEBIH KUAT
|
(Foto， Bawah: Bente bersama putranya, Per Jensen)
 (Ditulis bersama: Per Jensen)
Bente butuh bantuan. Saat didiagnosa dengan kanker melanoma ganas yang sudah menyebar, Bente melakukan apa yang setiap pasien lakukan: memulai pengobatan di tanah airnya dan berharap untuk sembuh.
Di tahun 2001 sesudah didiagnosa menderita kanker, Bente menjalani operasi dengan sukses di Denmark dan 5 tahun kemudian dinyatakan sembuh total.
Sayangnya kanker kambuh dan sudah menyebar di lutut kanan dan kedua sikunya di tahun 2008. Rencana pengobatan meliputi dosis tunggal interferon, kemudian dilanjutkan dengan Il2. Efek samping interferon amat berat baginya sampai tidak bisa melanjutkan dengan Il2. Berjalan dan bergerak menjadi makin sulit. Melihat keadaan ibunya semakin memburuk, kedua putranya berdiskusi dengan pasien lain dan mencari di internet untuk pengobatan terbaik yang ada, walaupun harus pergi ke negara yang jauh.
Apakah Bente kuatir bepergian jauh dari rumah? "Tidak...anak saya menemukan Fuda". Dalam wawancara, Bente menuturkan bahwa dokternya sudah menyerah, menyarankan dia pulang, beristirahat dan menikmati sisa waktu hidupnya. Pada 27 Maret 2009, Bente dan keluarganya datang ke Rumah Sakit Kanker Fuda di Guangzhou, China.
Di Fuda, dia menerima 2 siklus kemoterapi lokal dengan 200mg Dacarbazine (DTIC) dan 40mg Cisplatin(DPP), yang dimasukkan lewat pembuluh darah arteri iliac dan subclavian. Plus satu kali cryosurgeri dan brachiterapi (penanaman biji yodium aktif 125) untuk penyebaran di paha dan lutut kanannya. Akhirnya, imunoterapi dengan multi vaksin. Pada Juni 2009, Bente dan keluarga kembali ke Fuda untuk melanjutkan terapi bulan Maret. Kanker telah menyebar ke paha kanannya sehingga cryosurgery dan brachiterapi perlu dilakukan.
Selama dua kali berobat di Fuda, keluarga Jensen amat senang dengan keramahan dan layanan semua dokter, perawat dan penterjemah yang ada. Saat ini Bente merasa lebih sehat, lebih berenergi, sanggup berjalan dan bergerak dengan lebih baik.
Saat ini Bente berobat di Fuda untuk ketiga kalinya. Tujuan berobat telah tercapai: mengontrol tumor, meningkatkan kualitas hidup dan memperpanjang nyawa, dan pasien boleh terus menikmati hidup.
diterjemahkan oleh: lotus
|
14-year survival in a patient with advanced ethmoid sinus melanoma achieving mixed microbe vaccines
received mixed microbe vaccine (MMV) consisted of 7 kinds of commercialized bacterial vaccines and one kind of viral vaccine plus proper adjuvants, ...
Significant improvement of a case of advanced gastric carcinoma with multiple hepatic metastases who received combination treatment of Bevacizumab-5FU
Liver metastases, especially from gastric carcinoma, have poor prognosis. Here we describe a case with late-stage gastric carcinoma with multiple live...
A patient with metastatic iridic melanoma achieving long-term survival after percutaneous cryosurgery
A 54-year-old man with iridic melanoma who had multiple liver metastases 4 years after an iridocyclectomy. A total of 5 sessions of percutaneous cryos...
Feasibility and Safety of Percutaneous Cryoblation for Locally Advanced Pancreatic Cancer
Background: Ultrasound-guided percutaneous cryoablation of intra-abdominal malignancy such as liver and kidney tumors has increasingly been used. To o...
A case of advanced hepatocellular carcinoma with long survival and improved QOL from percutaneous cryosurgery
Surgical resection was thought to be the only curative treatment for hepatocellular carcinoma (HCC). However, most of HCC are inoperative at the time ...
received mixed microbe vaccine (MMV) consisted of 7 kinds of commercialized bacterial vaccines and one kind of viral vaccine plus proper adjuvants, ...
Significant improvement of a case of advanced gastric carcinoma with multiple hepatic metastases who received combination treatment of Bevacizumab-5FU
Liver metastases, especially from gastric carcinoma, have poor prognosis. Here we describe a case with late-stage gastric carcinoma with multiple live...
A patient with metastatic iridic melanoma achieving long-term survival after percutaneous cryosurgery
A 54-year-old man with iridic melanoma who had multiple liver metastases 4 years after an iridocyclectomy. A total of 5 sessions of percutaneous cryos...
Feasibility and Safety of Percutaneous Cryoblation for Locally Advanced Pancreatic Cancer
Background: Ultrasound-guided percutaneous cryoablation of intra-abdominal malignancy such as liver and kidney tumors has increasingly been used. To o...
A case of advanced hepatocellular carcinoma with long survival and improved QOL from percutaneous cryosurgery
Surgical resection was thought to be the only curative treatment for hepatocellular carcinoma (HCC). However, most of HCC are inoperative at the time ...
 | Cryosurgery (also called cryotherapy) is a treatment application where extreme cold is produced by a special equipment to destroy abnormal tissues. Click to read the book |
 | "Immunotherapy may be one of the only ways left to deal with cancer. We've gone as far as we can with chemotherapy. "-Dr.Herman Kattlove-Medical Editor for the American Cancer Society. Click to read the book |
Terms of Use | Sitemap | Copyright
Best if viewed with Internet Explorer
© 2002-2009. Fudahospital. All rights reserved.
